THE MODERN WAY OF DIAGNOSIS OF CERVICAL CANCER IN DIFFERENT AGES

Аннотация

Given that clinical prognosis still exhibits significant variability and is challenging to predict, more and more studies have been conducted to explore the biomarkers for the diagnosis and prognosis of cervical cancer. A study has revealed that, compared to the younger group, elderly patients (≥65) with cervical squamous carcinoma have a higher frequency of gene mutations. Moreover, these mutations are considered potential prognostic markers in the old populations. The analysis of patients with cervical pathology showed that 67% of the 2 main groups of patients had a certain number of diseases with the term cervical erosion. It is known that cervical erosion is a disease that is very rare and indicates desquamation of the epithelium, in this case, etiotropic treatment is recommended instead of destructive treatment. Many patients were treated with various destructive methods without additional examination and without an accurate diagnosis.